Salam Shaaban, n/a

Senior Director
Rubius Therapeutics

Poster(s):

• Tu132 - Induction of Antigen-Specific Immune Tolerance in Type 1 Diabetes by Antigen-Expressing Red Cell Therapeutics
  Tuesday, June 21, 2022

  6:15 PM – 7:45 PM PT